Since Norbrook’s establishment in 1968, there has been a substantial increase in the manufacturing standards required by both Regulatory Authorities and customers around the world. Both demand an ever increasing quality performance from manufacturers.
Due to our on-going capital investment programme, the range of facilities at Norbrook is constantly being enhanced and we now have capacity available in several of our manufacturing areas. These facilities are designed to meet the demands of the future and combine substantial economies of scale for the largest distributor while still providing the flexibility to cater for the particular needs of specific and perhaps smaller market niches.
The Norbrook ‘Quality Culture’ has ensured that approval by the world’s most rigorous regulatory systems, as well as by auditors of the major global healthcare companies is achieved on a regular basis. In the current climate of rationalisation and increasing demands on capital expenditure, Norbrook offers world class manufacturing facilities at very competitive costs and provides pharmaceutical companies a low cost, high quality alternative to investment in their own facilities.
Our Company has the technology and facilities available for a wide range of products.
| 
